CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that revenues for the first quarter of fiscal 2011 increased 8% to $113.2 million, compared to revenues in the first quarter of last year of $105.2 million. As previously disclosed, the first quarter of fiscal 2010 contained an extra week, contributing both incremental revenue and expenses of approximately $2 million. Net income increased 69% to $3.9 million for the quarter, compared to $2.3 million in the prior year. Diluted earnings per share were $0.18, compared to $0.11 in the prior year. Backlog at the end of the first quarter was approximately $13 million, as compared to approximately $14 million at the end of fiscal 2010 and to $17 million at the end of Q1 2010.
